Floyd Sallee

Floyd R. Sallee , MD,PhD

Volunteer Professor

UC Department of Psychiatry & Behavioral Neuroscience
PO Box 670559
Cincinnati, Ohio 45267-0559
Phone 513-558-8663
Email floyd.sallee@uc.edu

Professional Summary

DR. FLOYD SALLEE is a Professor of Psychiatry & Behavioral Neuroscience at the University of Cincinnati. Dr. Sallee received an A.B. from the University of Illinois in 1972, an M.D. from Southern Illinois University in 1978 and a Ph.D. in Pharmacology from the University of Pittsburgh in 1988. Dr. Sallee’s major areas of clinical interest include Tourette disorder, pediatric psychopharmacology, and ADHD. Current interests include novel GPCRs and their therapeutic potential for anxiety and obesity.

Education

Medical Degree: Southern Illinois University 1978

Doctoral Degree: University of Pittsburgh 1988 (Pharmacology)

Residency: University of Pittsburgh

Fellowship: University of Pittsburgh

Certifications

American Board of Psychiatry and Neurology (Child-Adolescent Psychiatry) (Certification Date: 09-30-1993 )

American Board of Psychiatry and Neurology (Psychiatry) (Certification Date: 11-30-1983 )

Clinical Interests

Child and Adolescent Psychiatry

Psychiatry

Research and Practice Interests

Dr. Sallee's major areas of clinical interest include Tourette disorder, pediatric psychopharmacology, and ADHD. Current interests include novel GPCRs and their therapeutic potential for anxiety and obesity.

Research Support

Investigators:Sallee, Floyd 12-01-2003 -06-30-2005 National Institute of Neurological Disorders and Stroke Attention Deficit Hyperactivity Disorder Phenotype Network: Animal Model to Clincal Trial Role:PI $438,892.00 Closed Level:Federal

Grant: #5-R01-NS-39087-07-A0-S0-E0 Investigators:Sallee, Floyd 12-01-2003 -07-31-2007 National Institute of Neurological Disorders and Stroke Clonidine in Attention Deficit Hyperactivity Disorder Role:PI $2,831,653.00 Closed Level:Federal

Investigators:Sallee, Floyd 05-01-2004 -06-30-2004 National Institute of Mental Health Pulse Loaded IV Clomipramine in Unresponsive OCD Role:PI $13,834.00 Closed Level:Federal

Grant: #1-R01-MH-57471-01-A0-S0-E0 Investigators:Sallee, Floyd 07-10-1999 -06-30-2002 National Institute of Mental Health Pulse Loaded, IV Clomipramine Study in Patients with Unresponsive OCD Role:PI $170,338.00 Closed Level:Federal

Grant: #NARSAD-06-01-A0-S0-E0 Investigators:Sallee, Floyd 09-15-1998 -09-14-2000 National Alliance for Research on Schizophrenia and Depression Pulse Intravenous Clompramine in Depressed Adolescents Role:PI $100,000.00 Closed Level:Private Non-Profit

Grant: #1 R01 MH081854-01A2 Investigators:Chakraborty, Ranajit; Deka, Ranjan; Sallee, Floyd; Welge, Jeffrey 08-01-2009 -05-31-2014 National Institute of Mental Health Cortical Excitability: Phenotype And Biomarker In ADHD Therapy Role:PI $2,264,230.00 Active Level:Federal

Publications

Peer Reviewed Publications

Sallee, Floyd R; Eaton, Katherine (2010. ) Guanfacine extended-release for attention-deficit/hyperactivity disorder (ADHD).Expert opinion on pharmacotherapy, , More Information

McGuire, Jennifer; Herman, James P; Horn, Paul S; Sallee, Floyd R; Sah, Renu (2010. ) Enhanced fear recall and emotional arousal in rats recovering from chronic variable stress.Physiology & behavior, , More Information

Estes, Anne-Marie; McAllen, Kathleen; Parker, Michael S; Sah, Renu; Sweatman, Trevor; Park, Edwards A; Balasubramaniam, Ambikaipakan; Sallee, Floyd R; Walker, Mary W; Parker, Steven L (2010. ) Maintenance of Y receptor dimers in epithelial cells depends on interaction with G-protein heterotrimers.Amino acids, , More Information

Parker, Michael S; Park, Edwards A; Sallee, Floyd R; Parker, Steven L (2010. ) Two intracellular helices of G-protein coupling receptors could generally support oligomerization and coupling with transducers.Amino acids, , More Information

Sah, Renu; Ekhator, Nosakhare N; Strawn, Jeffrey R; Sallee, Floyd R; Baker, Dewleen G; Horn, Paul S; Geracioti, Thomas D (2009. ) Low cerebrospinal fluid neuropeptide Y concentrations in posttraumatic stress disorder.Biological psychiatry, , 66 (7 ) ,705-7 More Information

Cannon, Michael; Pelham, William H; Sallee, F Randy; Palumbo, Donna R; Bukstein, Oscar; Daviss, W Burl (2009. ) Effects of clonidine and methylphenidate on family quality of life in attention-deficit/hyperactivity disorder.Journal of child and adolescent psychopharmacology, , 19 (5 ) ,511-7 More Information

McGuire, Jennifer; Herman, James P; Ghosal, Sriparna; Eaton, Katherine; Sallee, Floyd R; Sah, Renu (2009. ) Acid-sensing by the T cell death-associated gene 8 (TDAG8) receptor cloned from rat brain.Biochemical and biophysical research communications, , 386 (3 ) ,420-5 More Information

Findling, Robert L; Kauffman, Ralph; Sallee, Floyd R; Salazar, Daniel E; Sahasrabudhe, Vaishali; Kollia, Georgia; Kornhauser, David M; Vachharajani, Nimish N; Assuncao-Talbott, Sheila; Mallikaarjun, Suresh; Iwamoto, Taro; McQuade, Robert D; Boulton, David W; Blumer, Jeffrey (2009. ) An open-label study of aripiprazole: pharmacokinetics, tolerability, and effectiveness in children and adolescents with conduct disorder.Journal of child and adolescent psychopharmacology, , 19 (4 ) ,431-9 More Information

Sallee, Floyd R; Lyne, Andrew; Wigal, Timothy; McGough, James J (2009. ) Long-term safety and efficacy of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.Journal of child and adolescent psychopharmacology, , 19 (3 ) ,215-26 More Information

Parker, M S; Sah, R; Park, E A; Sweatman, T; Balasubramaniam, A; Sallee, F R; Parker, S L (2009. ) Oligomerization of the heptahelical G protein coupling receptors: a case for association using transmembrane helices. Mini reviews in medicinal chemistry, , 9 (3 ) ,329-39

Sallee, Floyd R; McGough, James; Wigal, Tim; Donahue, Jessica; Lyne, Andrew; Biederman, Joseph (2009. ) Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: a placebo-controlled trial.Journal of the American Academy of Child and Adolescent Psychiatry, , 48 (2 ) ,155-65 More Information

Estes, A M; Wong, Y Y; Parker, M S; Sallee, F R; Balasubramaniam, A; Parker, S L (2008. ) Neuropeptide Y (NPY) Y2 receptors of rabbit kidney cortex are largely dimeric.Regulatory peptides, , 150 (1-3 ) ,88-94 More Information

Findling, Robert L; Kauffman, Ralph E; Sallee, Floyd R; Carson, William H; Nyilas, Margaretta; Mallikaarjun, Suresh; Shoaf, Susan E; Forbes, Robert A; Boulton, David W; Pikalov, Andrei (2008. ) Tolerability and pharmacokinetics of aripiprazole in children and adolescents with psychiatric disorders: an open-label, dose-escalation study.Journal of clinical psychopharmacology, , 28 (4 ) ,441-6 More Information

Daviss, W Burleson; Patel, Nick C; Robb, Adelaide S; McDermott, Michael P; Bukstein, Oscar G; Pelham, William E; Palumbo, Donna; Harris, Peter; Sallee, Floyd R (2008. ) Clonidine for attention-deficit/hyperactivity disorder: II. ECG changes and adverse events analysis.Journal of the American Academy of Child and Adolescent Psychiatry, , 47 (2 ) ,189-98 More Information

Palumbo, Donna R; Sallee, Floyd R; Pelham, William E; Bukstein, Oscar G; Daviss, W Burleson; McDermott, Michael P (2008. ) Clonidine for attention-deficit/hyperactivity disorder: I. Efficacy and tolerability outcomes.Journal of the American Academy of Child and Adolescent Psychiatry, , 47 (2 ) ,180-8 More Information

Parker, Steven L; Parker, Michael S; Sah, Renu; Balasubramaniam, Ambikaipakan; Sallee, Floyd R (2008. ) Pertussis toxin induces parallel loss of neuropeptide Y Y1 receptor dimers and Gi alpha subunit function in CHO cells.European journal of pharmacology, , 579 (1-3 ) ,13-25 More Information

Spencer, Thomas J; Sallee, F Randy; Gilbert, Donald L; Dunn, David W; McCracken, James T; Coffey, Barbara J; Budman, Cathy L; Ricardi, Randall K; Leonard, Henrietta L; Allen, Albert J; Milton, Denai R; Feldman, Peter D; Kelsey, Douglas K; Geller, Daniel A; Linder, Steven L; Lewis, Donald W; Winner, Paul K; Kurlan, Roger M; Mintz, Mark (2008. ) Atomoxetine treatment of ADHD in children with comorbid Tourette syndrome.Journal of attention disorders, , 11 (4 ) ,470-81 More Information

Findling, Robert L; Bukstein, Oscar G; Melmed, Raun D; López, Frank A; Sallee, Floyd R; Arnold, L Eugene; Pratt, Raymond D (2008. ) A randomized, double-blind, placebo-controlled, parallel-group study of methylphenidate transdermal system in pediatric patients with attention-deficit/hyperactivity disorder. The Journal of clinical psychiatry, , 69 (1 ) ,149-59

Parker, M S; Sah, R; Balasubramaniam, A; Sallee, F R; Sweatman, T; Park, E A; Parker, S L (2008. ) Dimers of the neuropeptide Y (NPY) Y2 receptor show asymmetry in agonist affinity and association with G proteins.Journal of receptor and signal transduction research, , 28 (5 ) ,437-51 More Information

Parker, S L; Parker, M S; Estes, A M; Wong, Y Y; Sah, R; Sweatman, T; Park, E A; Balasubramaniam, A; Sallee, F R (2008. ) The neuropeptide Y (NPY) Y2 receptors are largely dimeric in the kidney, but monomeric in the forebrain.Journal of receptor and signal transduction research, , 28 (3 ) ,245-63 More Information

Parker, S L; Parker, M S; Sallee, F R; Balasubramaniam, A (2007. ) Oligomerization of neuropeptide Y (NPY) Y2 receptors in CHO cells depends on functional pertussis toxin-sensitive G-proteins.Regulatory peptides, , 144 (1-3 ) ,72-81 More Information

Beidel, Deborah C; Turner, Samuel M; Sallee, Floyd R; Ammerman, Robert T; Crosby, Lori A; Pathak, Sanjeev (2007. ) SET-C versus fluoxetine in the treatment of childhood social phobia.Journal of the American Academy of Child and Adolescent Psychiatry, , 46 (12 ) ,1622-32 More Information

Gilbert, Donald L; Zhang, Jie; Lipps, Tara D; Natarajan, Nina; Brandyberry, Jared; Wang, Zhewu; Sallee, F Randy; Wassermann, Eric M (2007. ) Atomoxetine treatment of ADHD in Tourette syndrome: reduction in motor cortex inhibition correlates with clinical improvement.Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, , 118 (8 ) ,1835-41 More Information

Rao, Patricia A; Beidel, Deborah C; Turner, Samuel M; Ammerman, Robert T; Crosby, Lori E; Sallee, Floyd R (2007. ) Social anxiety disorder in childhood and adolescence: descriptive psychopathology.Behaviour research and therapy, , 45 (6 ) ,1181-91 More Information

Parker, S L; Parker, M S; Sah, R; Sallee, F R; Balasubramaniam, A (2007. ) Parallel inactivation of Y2 receptor and G-proteins in CHO cells by pertussis toxin.Regulatory peptides, , 139 (1-3 ) ,128-35 More Information

Sah, Renu; Parker, Steven L; Sheriff, Sulaiman; Eaton, Katherine; Balasubramaniam, Ambikaipakan; Sallee, Floyd R (2007. ) Interaction of NPY compounds with the rat glucocorticoid-induced receptor (GIR) reveals similarity to the NPY-Y2 receptor.Peptides, , 28 (2 ) ,302-9 More Information

Parker, S L; Parker, M S; Sah, R; Balasubramaniam, A; Sallee, F R (2007. ) Self-regulation of agonist activity at the Y receptors.Peptides, , 28 (2 ) ,203-13 More Information

Eaton, Katherine; Sallee, Floyd R; Sah, Renu (2007. ) Relevance of neuropeptide Y (NPY) in psychiatry. Current topics in medicinal chemistry, , 7 (17 ) ,1645-59

Gilbert, D L; Christian, B T; Gelfand, M J; Shi, B; Mantil, J; Sallee, F R (2006. ) Altered mesolimbocortical and thalamic dopamine in Tourette syndrome.Neurology, , 67 (9 ) ,1695-7 More Information

Gilbert, Donald L; Wang, Zhewu; Sallee, Floyd R; Ridel, Keith R; Merhar, Stephanie; Zhang, Jie; Lipps, Tara D; White, Colin; Badreldin, Nevert; Wassermann, Eric M (2006. ) Dopamine transporter genotype influences the physiological response to medication in ADHD.Brain : a journal of neurology, , 129 (Pt 8 ) ,2038-46 More Information

Sallee, Floyd R; Miceli, Jeffrey J; Tensfeldt, Thomas; Robarge, Lisa; Wilner, Keith; Patel, Nick C (2006. ) Single-dose pharmacokinetics and safety of ziprasidone in children and adolescents.Journal of the American Academy of Child and Adolescent Psychiatry, , 45 (6 ) ,720-8 More Information

Ambrosini, Paul J; Sallee, Floyd R; Lopez, Frank A; Shi, Li; Michaels, M Alex (2006. ) A community assessment, open-label study of the safety, tolerability, and effectiveness of mixed amphetamine salts extended release in school-age children with ADHD.Current medical research and opinion, , 22 (2 ) ,427-40 More Information

Koran, Lorrin M; Aboujaoude, Elias; Ward, Herbert; Shapira, Nathan A; Sallee, Floyd R; Gamel, Nona; Elliott, Michael (2006. ) Pulse-loaded intravenous clomipramine in treatment-resistant obsessive-compulsive disorder. Journal of clinical psychopharmacology, , 26 (1 ) ,79-83

Gilbert, Donald L; Ridel, Keith R; Sallee, Floyd R; Zhang, Jie; Lipps, Tara D; Wassermann, Eric M (2006. ) Comparison of the inhibitory and excitatory effects of ADHD medications methylphenidate and atomoxetine on motor cortex.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, , 31 (2 ) ,442-9 More Information

Allen, A J; Kurlan, R M; Gilbert, D L; Coffey, B J; Linder, S L; Lewis, D W; Winner, P K; Dunn, D W; Dure, L S; Sallee, F R; Milton, D R; Mintz, M I; Ricardi, R K; Erenberg, G; Layton, L L; Feldman, P D; Kelsey, D K; Spencer, T J (2005. ) Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders.Neurology, , 65 (12 ) ,1941-9 More Information

Joiner, Thomas E; Brown, Jessica S; Perez, Marisol; Sethuraman, Gopalan; Sallee, Floyd R (2005. ) The illusion of mental health: in the mind of which beholder?.Journal of personality assessment, , 85 (1 ) ,92-7 More Information

Gilbert, Donald L; Sallee, Floyd R; Zhang, Jie; Lipps, Tara D; Wassermann, Eric M (2005. ) Transcranial magnetic stimulation-evoked cortical inhibition: a consistent marker of attention-deficit/hyperactivity disorder scores in tourette syndrome.Biological psychiatry, , 57 (12 ) ,1597-600 More Information

Matza, Louis S; Secnik, Kristina; Rentz, Anne M; Mannix, Sally; Sallee, F Randy; Gilbert, Donald; Revicki, Dennis A (2005. ) Assessment of health state utilities for attention-deficit/hyperactivity disorder in children using parent proxy report. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, , 14 (3 ) ,735-47

Sah, R; Pritchard, L M; Richtand, N M; Ahlbrand, R; Eaton, K; Sallee, F R; Herman, J P (2005. ) Expression of the glucocorticoid-induced receptor mRNA in rat brain.Neuroscience, , 133 (1 ) ,281-92 More Information

Matza, Louis S; Secnik, Kristina; Mannix, Sally; Sallee, F Randy (2005. ) Parent-proxy EQ-5D ratings of children with attention-deficit hyperactivity disorder in the US and the UK. PharmacoEconomics, , 23 (8 ) ,777-90

Carter, Kevin; Dickerson, Jon; Schoepp, Darryle D; Reilly, Melinda; Herring, Nicole; Williams, Jon; Sallee, Floyd R; Sharp, James W; Sharp, Frank R (2004. ) The mGlu2/3 receptor agonist LY379268 injected into cortex or thalamus decreases neuronal injury in retrosplenial cortex produced by NMDA receptor antagonist MK-801: possible implications for psychosis.Neuropharmacology, , 47 (8 ) ,1135-45 More Information

Sallee, Floyd R; Smirnoff, Alexander V (2004. ) Adderall XR: long acting stimulant for single daily dosing.Expert review of neurotherapeutics, , 4 (6 ) ,927-34 More Information

Chae, Jeong-Ho; Nahas, Ziad; Wassermann, Eric; Li, Xingbao; Sethuraman, Gopalan; Gilbert, Donald; Sallee, Floyd R; George, Mark S (2004. ) A pilot safety study of repetitive transcranial magnetic stimulation (rTMS) in Tourette's syndrome. Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology, , 17 (2 ) ,109-17

Dutta, Sandeep; Zhang, Yiming; Conway, Jeannine M; Sallee, Floyd R; Biton, Victor; Reed, Michael D; Kearns, Gregory L (2004. ) Divalproex-ER pharmacokinetics in older children and adolescents.Pediatric neurology, , 30 (5 ) ,330-7 More Information

Gilbert, Donald L; Bansal, Alok S; Sethuraman, Gopalan; Sallee, Floyd R; Zhang, Jie; Lipps, Tara; Wassermann, Eric M (2004. ) Association of cortical disinhibition with tic, ADHD, and OCD severity in Tourette syndrome.Movement disorders : official journal of the Movement Disorder Society, , 19 (4 ) ,416-25 More Information

Barzman, Drew H; Fieler, Lisha; Sallee, Floyd R (2004. ) Attention-deficit hyperactivity disorder diagnosis and treatment. Separating myth from substance. The Journal of legal medicine, , 25 (1 ) ,23-38

Gilbert, Donald L; Batterson, J Robert; Sethuraman, Gopalan; Sallee, Floyd R (2004. ) Tic reduction with risperidone versus pimozide in a randomized, double-blind, crossover trial.Journal of the American Academy of Child and Adolescent Psychiatry, , 43 (2 ) ,206-14 More Information

Barzman, Drew H.; Fieler, Lisha; Sallee, Floyd R. (2004. ) Attention-Deficit Hyperactivity Disorder Diagnosis and Treatment. The Journal of legal medicine, , 25 (1 ) ,23-38

Sallee, Floyd R; Gilbert, Donald L; Vinks, Alexander A; Miceli, Jeffrey J; Robarge, Lisa; Wilner, Keith (2003. ) Pharmacodynamics of ziprasidone in children and adolescents: impact on dopamine transmission.Journal of the American Academy of Child and Adolescent Psychiatry, , 42 (8 ) ,902-7 More Information

Upadhyaya, Himanshu P; Brady, Kathleen T; Liao, Jason; Sethuraman, Gopalan; Middaugh, Larry; Wharton, Mollie; Sallee, Floyd R (2003. ) Neuroendocrine and behavioral responses to dopaminergic agonists in adolescents with alcohol abuse.Psychopharmacology, , 166 (2 ) ,95-101 More Information

Gilbert, D L; Dure, L; Sethuraman, G; Raab, D; Lane, J; Sallee, F R (2003. ) Tic reduction with pergolide in a randomized controlled trial in children. Neurology, , 60 (4 ) ,606-11

Sallee, Floyd R Pediatric drug research and mental illness. FDA consumer, , 37 (1 ) ,40

Liebowitz, Michael R; Turner, Samuel M; Piacentini, John; Beidel, Deborah C; Clarvit, Susan R; Davies, Sharon O; Graae, Flemming; Jaffer, Margaret; Lin, Shu-Hsing; Sallee, Floyd R; Schmidt, Andrew B; Simpson, H Blair (2002. ) Fluoxetine in children and adolescents with OCD: a placebo-controlled trial.Journal of the American Academy of Child and Adolescent Psychiatry, , 41 (12 ) ,1431-8 More Information

Michelson, David; Allen, Albert J; Busner, Joan; Casat, Charles; Dunn, David; Kratochvil, Christopher; Newcorn, Jeffrey; Sallee, F Randy; Sangal, R Bart; Saylor, Keith; West, Scott; Kelsey, Douglas; Wernicke, Joachim; Trapp, Nancy J; Harder, Donald (2002. ) Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study. The American journal of psychiatry, , 159 (11 ) ,1896-901

Wang, D; Herman, J P; Pritchard, L M; Spitzer, R H; Ahlbrand, R L; Kramer, G L; Petty, F; Sallee, F R; Richtand, N M (2001. ) Cloning, expression, and regulation of a glucocorticoid-induced receptor in rat brain: effect of repetitive amphetamine. The Journal of neuroscience : the official journal of the Society for Neuroscience, , 21 (22 ) ,9027-35

Michelson, D; Faries, D; Wernicke, J; Kelsey, D; Kendrick, K; Sallee, F R; Spencer, T (2001. ) Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, dose-response study. Pediatrics, , 108 (5 ) ,E83

George, M S; Sallee, F R; Nahas, Z; Oliver, N C; Wassermann, E M (2001. ) Transcranial magnetic stimulation (TMS) as a research tool in Tourette syndrome and related disorders. Advances in neurology, , 85 ,225-35

Sallee, Floyd R; Vrindavanam, Nandagopal S; Liu, Hong; Sethuraman, Gopalan; Sine, Lauren (2000. ) Fenfluramine challenge in anxious children.Human psychopharmacology, , 15 (8 ) ,619-629 More Information

Sallee, F R; Sethuraman, G; Sine, L; Liu, H (2000. ) Yohimbine challenge in children with anxiety disorders. The American journal of psychiatry, , 157 (8 ) ,1236-42

Sallee, F R; DeVane, C L; Ferrell, R E (2000. ) Fluoxetine-related death in a child with cytochrome P-450 2D6 genetic deficiency. Journal of child and adolescent psychopharmacology, , 10 (1 ) ,27-34

Gilbert, D L; Sethuraman, G; Sine, L; Peters, S; Sallee, F R (2000. ) Tourette's syndrome improvement with pergolide in a randomized, double-blind, crossover trial. Neurology, , 54 (6 ) ,1310-5

Sallee, F R; Kurlan, R; Goetz, C G; Singer, H; Scahill, L; Law, G; Dittman, V M; Chappell, P B (2000. ) Ziprasidone treatment of children and adolescents with Tourette's syndrome: a pilot study.Journal of the American Academy of Child and Adolescent Psychiatry, , 39 (3 ) ,292-9 More Information

Mehlman, P T; Westergaard, G C; Hoos, B J; Sallee, F R; Marsh, S; Suomi, S J; Linnoila, M; Higley, J D (2000. ) CSF 5-HIAA and nighttime activity in free-ranging primates.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, , 22 (2 ) ,210-8 More Information

Shader, R I; Harmatz, J S; Oesterheld, J R; Parmelee, D X; Sallee, F R; Greenblatt, D J (1999. ) Population pharmacokinetics of methylphenidate in children with attention-deficit hyperactivity disorder. Journal of clinical pharmacology, , 39 (8 ) ,775-85

March, J S; Biederman, J; Wolkow, R; Safferman, A; Mardekian, J; Cook, E H; Cutler, N R; Dominguez, R; Ferguson, J; Muller, B; Riesenberg, R; Rosenthal, M; Sallee, F R; Wagner, K D; Steiner, H (1998. ) Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial. JAMA : the journal of the American Medical Association, , 280 (20 ) ,1752-6

Sallee, F R; Vrindavanam, N S; Deas-Nesmith, D; Odom, A M; Carson, S W; Sethuraman, G (1998. ) Parenteral clomipramine challenge in depressed adolescents: mood and neuroendocrine response. Biological psychiatry, , 44 (7 ) ,562-7

Sallee, F R; Koran, L M; Pallanti, S; Carson, S W; Sethuraman, G (1998. ) Intravenous clomipramine challenge in obsessive-compulsive disorder: predicting response to oral therapy at eight weeks. Biological psychiatry, , 44 (3 ) ,220-7

Sallee, F R; Hilal, R; Dougherty, D; Beach, K; Nesbitt, L (1998. ) Platelet serotonin transporter in depressed children and adolescents: 3H-paroxetine platelet binding before and after sertraline.Journal of the American Academy of Child and Adolescent Psychiatry, , 37 (7 ) ,777-84 More Information

Sallee, F R; Richman, H; Sethuraman, G; Dougherty, D; Sine, L; Altman-Hamamdzic, S (1998. ) Clonidine challenge in childhood anxiety disorder.Journal of the American Academy of Child and Adolescent Psychiatry, , 37 (6 ) ,655-62 More Information

Groseclose, C H; Draughn, R A; Tyor, W R; Sallee, F R; Middaugh, L D (1998. ) Long-term intracranial cannula stabilization in mice with light cured resin composites. Journal of neuroscience methods, , 79 (1 ) ,31-6

Mehlman, P T; Higley, J D; Fernald, B J; Sallee, F R; Suomi, S J; Linnoila, M (1997. ) CSF 5-HIAA, testosterone, and sociosexual behaviors in free-ranging male rhesus macaques in the mating season. Psychiatry research, , 72 (2 ) ,89-102

Sallee, F R; Nesbitt, L; Jackson, C; Sine, L; Sethuraman, G (1997. ) Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder. The American journal of psychiatry, , 154 (8 ) ,1057-62

Altman-Hamamdzic, S; Groseclose, C; Ma, J X; Hamamdzic, D; Vrindavanam, N S; Middaugh, L D; Parratto, N P; Sallee, F R (1997. ) Expression of beta-galactosidase in mouse brain: utilization of a novel nonreplicative Sindbis virus vector as a neuronal gene delivery system.Gene therapy, , 4 (8 ) ,815-22 More Information

Sallee, F R; Vrindavanam, N S; Deas-Nesmith, D; Carson, S W; Sethuraman, G (1997. ) Pulse intravenous clomipramine for depressed adolescents: double-blind, controlled trial. The American journal of psychiatry, , 154 (5 ) ,668-73

Lipinski, J F; Sallee, F R; Jackson, C; Sethuraman, G (1997. ) Dopamine agonist treatment of Tourette disorder in children: results of an open-label trial of pergolide.Movement disorders : official journal of the Movement Disorder Society, , 12 (3 ) ,402-7 More Information

Koran, L M; Sallee, F R; Pallanti, S (1997. ) Rapid benefit of intravenous pulse loading of clomipramine in obsessive-compulsive disorder. The American journal of psychiatry, , 154 (3 ) ,396-401

Sallee, F R; Richman, H; Beach, K; Sethuraman, G; Nesbitt, L (1996. ) Platelet serotonin transporter in children and adolescents with obsessive-compulsive disorder or Tourette's syndrome.Journal of the American Academy of Child and Adolescent Psychiatry, , 35 (12 ) ,1647-56 More Information

Sallee, F R; Dougherty, D; Sethuraman, G; Vrindavanam, N (1996. ) Prolactin monitoring of haloperidol and pimozide treatment in children with Tourette's syndrome.Biological psychiatry, , 40 (10 ) ,1044-50 More Information

Vrindavanam, N S; Arnaud, P; Ma, J X; Altman-Hamamdzic, S; Parratto, N P; Sallee, F R (1996. ) The effects of phosphorylation on the functional regulation of an expressed recombinant human dopamine transporter. Neuroscience letters, , 216 (2 ) ,133-6

Stepniakowski, K T; Sallee, F R; Goodfriend, T L; Zhang, Z; Egan, B M (1996. ) Fatty acids enhance neurovascular reflex responses by effects on alpha 1-adrenoceptors. The American journal of physiology, , 270 (6 Pt 2 ) ,R1340-6

DeVane, C L; Sallee, F R (1996. ) Serotonin selective reuptake inhibitors in child and adolescent psychopharmacology: a review of published experience. The Journal of clinical psychiatry, , 57 (2 ) ,55-66

Sallee, F R; Katikaneni, L P; McArthur, P D; Ibrahim, H M; Nesbitt, L; Sethuraman, G (1995. ) Head growth in cocaine-exposed infants: relationship to neonate hair level. Journal of developmental and behavioral pediatrics : JDBP, , 16 (2 ) ,77-81

Sallee, F R; Nesbitt, L; Dougherty, D; Hilal, R; Nandagopal, V S; Sethuraman, G (1995. ) Lymphocyte glucocorticoid receptor: predictor of sertraline response in adolescent major depressive disorder (MDD). Psychopharmacology bulletin, , 31 (2 ) ,339-45

Sallee, F R; Sethuraman, G; Rock, C M (1994. ) Effects of pimozide on cognition in children with Tourette syndrome: interaction with comorbid attention deficit hyperactivity disorder. Acta psychiatrica Scandinavica, , 90 (1 ) ,4-9

Lonigan, C J; Shannon, M P; Taylor, C M; Finch, A J; Sallee, F R (1994. ) Children exposed to disaster: II. Risk factors for the development of post-traumatic symptomatology. Journal of the American Academy of Child and Adolescent Psychiatry, , 33 (1 ) ,94-105

Fletcher, S E; Case, C L; Sallee, F R; Hand, L D; Gillette, P C (1993. ) Prospective study of the electrocardiographic effects of imipramine in children. The Journal of pediatrics, , 122 (4 ) ,652-4

George, M S; Trimble, M R; Ring, H A; Sallee, F R; Robertson, M M (1993. ) Obsessions in obsessive-compulsive disorder with and without Gilles de la Tourette's syndrome. The American journal of psychiatry, , 150 (1 ) ,93-7

Sallee, F R; Kopp, U; Hanin, I (1992. ) Controlled study of erythrocyte choline in Tourette syndrome. Biological psychiatry, , 31 (12 ) ,1204-12

Sallee, F R; Stiller, R L; Perel, J M (1992. ) Pharmacodynamics of pemoline in attention deficit disorder with hyperactivity.Journal of the American Academy of Child and Adolescent Psychiatry, , 31 (2 ) ,244-51 More Information

Sallee, F R; Pollock, B G (1990. ) Clinical pharmacokinetics of imipramine and desipramine. Clinical pharmacokinetics, , 18 (5 ) ,346-64

Niznik, H B; Tyndale, R F; Sallee, F R; Gonzalez, F J; Hardwick, J P; Inaba, T; Kalow, W (1990. ) The dopamine transporter and cytochrome P45OIID1 (debrisoquine 4-hydroxylase) in brain: resolution and identification of two distinct [3H]GBR-12935 binding proteins. Archives of biochemistry and biophysics, , 276 (2 ) ,424-32

Sallee, F R; Fogel, E L; Schwartz, E; Choi, S M; Curran, D P; Niznik, H B (1989. ) Photoaffinity labeling of the mammalian dopamine transporter. FEBS letters, , 256 (1-2 ) ,219-24

Sallee, F R; Stiller, R L; Perel, J M; Everett, G (1989. ) Pemoline-induced abnormal involuntary movements. Journal of clinical psychopharmacology, , 9 (2 ) ,125-9

Sallee, F R; Pollock, B G; Perel, J M; Ryan, N D; Stiller, R L (1989. ) Intravenous pulse loading of clomipramine in adolescents with depression. Psychopharmacology bulletin, , 25 (1 ) ,114-8

Sallee, F R; Pollock, B G; Stiller, R L; Stull, S; Everett, G; Perel, J M (1987. ) Pharmacokinetics of pimozide in adults and children with Tourette's syndrome. Journal of clinical pharmacology, , 27 (10 ) ,776-81

Keywords

Pharmacoeconomics(MeSH PhrmEco),Transdermal Drug Delivery(MeSH TrDrgDel),Pharmacokinetics(MeSH PhrmKin),Vertebrates(MeSH B02),Nervous System Diseases(MeSH C10),Central Nervous System Agents(MeSH D15),Therapeutics(MeSH E02),Investigative Techniques(MeSH E05),Behavior and Behavior Mechanisms(MeSH F01),Psychological Phenomena and Processes(MeSH F02),Mental Disorders(MeSH F03),Chemical and Pharmacologic Phenomena(MeSH G12)

Other Information

Floyd Sallee, MD, PhD, is a physician with University of Cincinnati Physicians.

Practice Location:
UC Health Psychiatry (Stetson Building)
260 Stetson Street, Suite 3200
Cincinnati, Ohio 45219

Clinical Specialties:
Psychiatry/Psychology, ADD/ADHD, Child Psychiatry/Psychology

To make an appointment, please call (513) 475-8000.


 UC Health logo

,

Contact Information

Academic - UC Department of Psychiatry & Behavioral Neuroscience
PO Box 670559
Cincinnati  Ohio, 45267-0559
Phone: 513-558-8663
floyd.sallee@uc.edu